Literature DB >> 3945861

Piperacillin-induced anemia and leukopenia.

R B Bressler, D P Huston.   

Abstract

Piperacillin is being used with increasing frequency as an important antibiotic for the treatment of severe and life-threatening infections. Many of these patients may have multiple possible causes of leukopenia and/or anemia. An awareness of the potential for piperacillin to cause the rapid onset of leukopenia and/or anemia may have important therapeutic implications, especially in severely ill patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945861     DOI: 10.1097/00007611-198602000-00031

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

1.  Immune-mediated severe hemolytic crisis with a hemoglobin level of 1.6 g/dl caused by anti-piperacillin antibodies in a patient with cystic fibrosis.

Authors:  S Kunzmann; W Thomas; B Mayer; S Kuhn; H Hebestreit
Journal:  Infection       Date:  2010-03-05       Impact factor: 3.553

2.  Piperacillin-induced mild haemolytic anaemia in a 44-year-old patient with cystic fibrosis.

Authors:  Carolin Meinus; Carsten Schwarz; Beate Mayer; J F Roehmel
Journal:  BMJ Case Rep       Date:  2016-10-24

3.  Piperacillin/tazobactam Induced Myelosuppression.

Authors:  Kirsty Wai Chung Lee; Kai Ming Chow; Natalie Pui Ha Chan; Angeline Oi Shan Lo; Cheuk Chun Szeto
Journal:  J Clin Med Res       Date:  2009-03-24

4.  Piperacillin induced bone marrow suppression: a case report.

Authors:  Ashish Kumar; Gourdas Choudhuri; Rakesh Aggarwal
Journal:  BMC Clin Pharmacol       Date:  2003-06-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.